Matrix Partners has raised $450 million for its 11th U.S. venture capital fund, according to a document filed with securities regulators.
That’s the same size as Matrix’s last fund, which it closed in 2013. That’s somewhat unusual in the current... Read more »
The window for biotech IPOs remains wide open and six more companies have charged through it, raising more than $568 million in the span of 24 hours.
The first was Eidos Therapeutics (NASDAQ: EIDX), which raised $106 million in its... Read more »
Analog Devices, the 53-year-old semiconductor company, threw a party Tuesday afternoon to celebrate its new technology incubator in Boston, dubbed the Analog Garage—an homage to the innovations that have originated in garages, basements, and other “nondescript quarters” of the world, as... Read more »
The new, independent, healthcare-focused company Amazon, Berkshire Hathaway, and JPMorgan Chase plan to launch made a big splash when it was first announced in January, but few details have emerged since.
On Wednesday, the trio of American business heavyweights revealed... Read more »
NGINX Inc., a Web application delivery platform company built on the open-source Web server NGINX, announced today it raised $43 million in a Series C fundraising to advance its system for helping clients modernize their websites.
The funding round,... Read more »
CrowdStrike, a Silicon Valley cybersecurity company that fends off hackers by patrolling the edge devices connected to a network, announced today it raised $200 million in a financing round that sets the company’s valuation at more than $3 billion.
Sunnyvale,... Read more »
CVS Health said Tuesday that it has expanded its prescription-drug delivery service nationwide. Customers of the Rhode Island-based retail pharmacy giant, which operates about 9,800 stores in the U.S., will be able to get their medications, as well as over-the-counter items,... Read more »
Roche this morning agreed to acquire the part of Foundation Medicine it didn’t already own, another big vote of confidence in tests that analyze a patient’s cancer genes and the drugs that can target them.
Roche will pay $137 per share,... Read more »
It’s far too early to say whether gene therapy can treat Duchenne muscular dystrophy, a deadly genetic disease. But the first clinical data have arrived, with Sarepta Therapeutics today reporting encouraging preliminary results from three patients.
Sarepta (NASDAQ: SRPT), of... Read more »
Boston-based ezCater, which runs an online food-ordering service for businesses, said today it has $100 million in new money. The Series D financing round was led by Wellington Management Company, with previous investors including Iconiq Capital and Insight Venture Partners... Read more »
Uptycs is starting to make some noise. Today, the two-year-old cybersecurity startup announced a $10 million Series A funding round to help expand its team and advance its security analytics software.
The investment was led by ForgePoint Capital, a cybersecurity-focused... Read more »
Emulate, a Boston-based startup that has developed small laboratory chips intended to replace the animal tests used in pharmaceutical research, has raised $36 million in financing.
The Series C round of funding was led by Founders Fund. Also participating in the... Read more »